A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration
- PMID: 21207049
- DOI: 10.1007/s00406-010-0184-0
A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration
Abstract
This study presents a visual rating scale for the assessment of cerebral [(18)F]fluoro-2-deoxy-D: -glucose positron emission tomography (FDG-PET) scans to characterize typical findings in dementias associated with frontotemporal lobar degeneration (FTLD) and to differentiate individual patients with FTLD compared to Alzheimer's disease (AD) and mild cognitive impairment (MCI). A total of 43 cerebral PET scans from patients with FTLD (n = 16, mean age 58.4 years), AD (n = 16, 59.9 years) and MCI (n = 11, 57.9 years) were analysed. Every PET data set was visually rated for seven brain regions on each hemisphere (frontal lobe, temporal lobe, parietal lobe, occipital lobe, basal ganglia, thalamus and cerebellum). The extent of the impairment in metabolism was classified as absent, mild, medium or strong. Using this four-stage visual rating scale, characteristic profiles of metabolic impairment in FTLD, AD, MCI and the FTLD-subgroup FTD (n = 9) could be demonstrated. Patients with FTLD showed a significantly lower metabolism in the left frontal lobe and in the left basal ganglia when compared to AD and to MCI. Complementary analyses using statistical parametric mapping (SPM2) supported the findings of the visual analysis. In detecting FTLD with visual rating, sensitivity/specificity was 81/94% compared to AD and 81/64% compared to MCI. Patients with FTD were correctly attributed to a diagnosis of FTLD with a sensitivity of 89%. This visual rating scale may facilitate the differential diagnosis of FTLD in clinical routine.
Similar articles
-
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.Arch Neurol. 2011 Mar;68(3):329-37. doi: 10.1001/archneurol.2010.295. Epub 2010 Nov 8. Arch Neurol. 2011. PMID: 21059987 Free PMC article.
-
18F-FDG PET for the differential diagnosis of Alzheimer's disease and frontotemporal lobar degeneration: A multicenter prospective study in Japan.J Alzheimers Dis. 2025 Jul;106(1):293-303. doi: 10.1177/13872877251338691. Epub 2025 May 5. J Alzheimers Dis. 2025. PMID: 40325872 Free PMC article.
-
Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.Neurology. 2011 Dec 6;77(23):2034-42. doi: 10.1212/WNL.0b013e31823b9c5e. Epub 2011 Nov 30. Neurology. 2011. PMID: 22131541 Free PMC article.
-
Clinical utility of FDG-PET for the clinical diagnosis in MCI.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1497-1508. doi: 10.1007/s00259-018-4039-7. Epub 2018 Apr 27. Eur J Nucl Med Mol Imaging. 2018. PMID: 29704037 Review.
-
Brain fluorodeoxyglucose (FDG) PET in dementia.Ageing Res Rev. 2016 Sep;30:73-84. doi: 10.1016/j.arr.2016.02.003. Epub 2016 Feb 11. Ageing Res Rev. 2016. PMID: 26876244 Review.
Cited by
-
Achievement and maintenance of the new impact factor 2010.Eur Arch Psychiatry Clin Neurosci. 2011 Sep;261(6):387-9. doi: 10.1007/s00406-011-0237-z. Eur Arch Psychiatry Clin Neurosci. 2011. PMID: 21861244 Free PMC article. No abstract available.
-
Systematic review of the diagnostic utility of SPECT imaging in dementia.Eur Arch Psychiatry Clin Neurosci. 2013 Oct;263(7):539-52. doi: 10.1007/s00406-013-0426-z. Epub 2013 Aug 6. Eur Arch Psychiatry Clin Neurosci. 2013. PMID: 23917803
-
Dissecting the Many Faces of Frontotemporal Dementia: An Imaging Perspective.Int J Mol Sci. 2022 Oct 25;23(21):12867. doi: 10.3390/ijms232112867. Int J Mol Sci. 2022. PMID: 36361654 Free PMC article. Review.
-
Altered Brain Expression of Insulin and Insulin-Like Growth Factors in Frontotemporal Lobar Degeneration: Another Degenerative Disease Linked to Dysregulation of Insulin Metabolic Pathways.ASN Neuro. 2019 Jan-Dec;11:1759091419839515. doi: 10.1177/1759091419839515. ASN Neuro. 2019. PMID: 31081340 Free PMC article.
-
Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.Eur J Nucl Med Mol Imaging. 2018 Jul;45(9):1509-1525. doi: 10.1007/s00259-018-4035-y. Epub 2018 May 7. Eur J Nucl Med Mol Imaging. 2018. PMID: 29736698 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources